Is the domestic price of Secukinumab high?

The original drug Secukinumab (Secukinumab) has been launched in China and has entered the scope of Class B medical insurance. However, domestic patients who can purchase this drug are limited to eligible patients. Patients who are not eligible for medical insurance reimbursement can only purchase it at their own expense. The price of each box of 150mg/ML is around RMB 1,000. Secukinumab is injected subcutaneously once a week for 5 weeks, and then once a month as maintenance treatment. Patients using this drug for long-term treatment may be more expensive.

Secukinumab has significant clinical benefit in patients with psoriasis, psoriatic arthritis, axial arthritis, enthesitis-associated arthritis, and juvenile psoriatic arthritis, and has also been shown to provide relevant therapeutic benefits in adult patients with moderate to severe hidradenitis suppurativa, a disease with few systemic treatment options. There is limited information on long-term use in patients with hidradenitis suppurativa, and studies are ongoing to evaluate this. Safety was considered reassuring, with the main concern being mild infections.

The benefits of secukinumab outweigh its risks and it is authorized for use, but only by prescription and should be administered under the supervision and guidance of a physician experienced in diagnosing and treating the condition for which secukinumab is used. SecukinumabThe original drug has also been launched overseas. The specifications of the Turkish original versionThe price per box of 150mg/ML is about 1,500 yuan, and the European version is 150mg/ML. *The price of each box of 2 pills is around RMB 15,000 (the price may fluctuate due to the exchange rate). The ingredients of foreign original drugs are basically the same as those of domestic original drugs. Currently, there are no generic secukinumab drugs on the market.